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Abstract 
Decline in cognitive abilities is a major concern in aging individuals. A potential important factor for functioning of the 
central nervous system in late life stages is the KLOTHO (KL) gene. KL is expressed in various organs including the 
brain, and is involved in multiple biological processes e.g. growth factor signaling. In the present study, nineteen 
tagging gene variants in KL were studied in relation to two measures of cognitive function, a 5-item cognitive 
composite score (CCS) and the Mini Mental State Examination (MMSE), in 1,480 Danes 92-100 years of age. We found 
that heterozygotes for the previously reported KL-VS had poorer cognitive function than non-carriers. Two other 
variants positioned in the 5’end of the gene, rs398655 and rs562020, were associated with better cognitive function 
independently of KL-VS, and the common haplotype AG was associated with poorer cognition, consistently across two 
cognitive measures in two cohort strata. The haplotype effect was stronger than that of KL-VS. Two variants, 
rs2283368 and rs9526984 were the only variants significantly associated with cognitive decline over seven years. We 
discuss an age dependent effect of KL and the possibility that multiple gene variants in KL are important for cognitive 
function among the oldest old. 
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Introduction 
The goddess Clotho, who in the ancient Greek mythology was known to spin the thread of life, has lend her name to a 
gene, which, when mutated in mice, leads to multiple disorders resembling human aging and to a shortened life span 
(1). In addition, genetic klotho reduction in mice during embryogenesis has been shown to cause early postnatal 
death, hypomyelination (2), synaptic attrition (3), and cognitive impairment (4), suggesting that klotho is required for 
brain maturation. The mouse Klotho gene encodes a single-pass transmembrane protein that is predominantly 
expressed in the choroid plexus of the brain, distal tubule cells of the kidney, and parathyroid glands (5). The 
extracellular domain of the klotho protein is subject to ectodomain shedding, and as a result, the Klotho protein exists 
in 2 forms: membrane and secreted klotho (5). The secreted protein acts as a humoral factor with pleiotropic activities 
in the mouse, including maintenance of vascular integrity and inflammation (6), but also suppression of both growth 
factor signaling and oxidative stress, the latter with homology in human cells (7). Redundant mouse/human homology 
was found for the soluble form of klotho, which circulates in serum and cerebrospinal fluid throughout life and 
declines with aging (8-11). In parallel to the putative emergence of cognitive deficits, it is possible that klotho also 
fulfills important functions in the central nervous system in both early and later life stages.  
 
The human homologue of the KLOTHO gene (KL), is composed of 5 exons and covers more than 50 kb on chromosome 
13q12 (1). Variants in KL show a large degree of pleiotropic associations including associations to carotid 
atherosclerosis (12), cardiovascular risk factors such as fasting glucose, lipid levels and blood pressure (13-18), kidney 
stones (19), and bone related conditions (20-22). Additionally, age-related changes in the frequency of KL gene 
variants have been reported in several studies (15, 18, 23-26).  
 
There are three variants in the human KL gene that have been analyzed in numerous association studies. A common 
haplotype, KL–VS, consists of six sequence variants, two of which are located in exon 2 and result in the amino acid 
substitutions, F352V and C370S. Due to the presence of perfect linkage disequilibrium (LD) across the six KL-VS SNPs, 
the variant F352V (rs9536314) has often been used to tag the KL–VS haplotype. KL-VS influence both the functional 
trafficking and the catalytic activity of KLOTHO (15) and it has been associated with intelligence in individuals assessed 
both as tweens and as elderly (27). Recently, consistency was found in three independent cohorts of primarily 
Caucasians without dementia or cognitive complaints, where the KL-VS heterozygotes were found to have significantly 
increased cognitive Z-scores (28). Also, heterozygous carriers of the KL-VS haplotype had higher serum KLOTHO levels 
than non-carriers, which correlated with better cognition (28), thus supporting the relevance of KLOTHO in cognitive 
functioning. Another well-studied variant, C1818T (rs564481), is a synonymous variant located in the fourth exon and 
it is therefore not likely to be functional by itself. However, the variant may, nevertheless, be a clinically relevant 
marker as it has been found to associate with cardiovascular risk factors such as fasting glucose, lipid levels and blood 
pressure, although so far mainly in populations of Asian descent (13, 16). The third variant, G395A (rs1207568) (19, 
22), is located in the promotor region and may indeed be a functional variant, since it alters the DNA-protein affinity in 
cultures of human kidney cells (20). The interest in these two latter mentioned genetic variants has of course been 
driven by their association with biological conditions, but also for their abundancy in all three major population groups 
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i.e. Asians, Africans and Caucasians. In contrast, the KL-VS variant is very rare in the Asian populations (20, 29, 30). To 
our knowledge C1818T (rs564481) and G395A (rs1207568) have not previously been reported in relation to cognitive 
function. 
 
In this study, we first investigated whether the minor allele of the KL-VS variant, rs9536314 (F352V), is associated with 
a higher cognitive level and a slower cognitive decline in a large population of oldest old Danes. We also tested 
nineteen tagging variants, of which no a priory hypothesis was applied for eighteen variants in relation to cognition, 
thereby covering the majority of the genetic variation in KL. The study population comprised three birth cohorts of 
oldest old Danes, who were assessed by two panels of cognitive tests. In one cohort, the 1905 birth cohort, cognitive 
tests were assessed repeatedly with up to seven years of follow-up, and in this cohort the effect of the KL gene 
variants were studied both at a cross-sectional cognitive level and by the longitudinal change in cognition. 
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Materials and Methods 
Subjects 
The participants included in this study were drawn from three population-based nationwide surveys conducted at the 
University of Southern Denmark: The Danish 1905 birth cohort Study (31), the Danish 1910 birth cohort Study 
(unpublished data) and the Danish 1915 birth cohort Study (32). The Danish 1905 birth cohort Study is a prospective 
investigation of an entire Danish birth cohort. The survey was initiated in 1998, when the participants were 92-93 
years old and followed by three follow-up studies of the participating survivors in 2000, 2003 and 2005. Of the 3,600 
individuals still alive at intake, 2,262 participated, and 1,651 provided either a blood spot sample or a cheek swap at 
their first assessment in 1998. The Danish 1910 and 1915 birth cohort studies include Danes born in 1910 and 1915, 
respectively, who were alive and living in Denmark on September 1st 2010. Among 400 invited participants from the 
1910 birth cohort study, 273 participated and 176 provided blood samples. In the 1915 birth cohort study, 2,509 
individuals were identified as eligible participants when they were 95 years old, 1,584 individuals participated and 
1,165 individuals provided biological samples (32). Each of the surveys in the cohort studies comprises 
multidimensional face-to-face interviews and assessments of cognitive and physical functioning. Written informed 
consents were obtained from all participants and all three surveys were approved by the The Regional Scientific 
Ethical Committees for Southern Denmark. 
 
Assessment of cognitive function 
Cognitive functioning was assessed by using a 5-component cognitive composite score and the Mini Mental State 
Examination (MMSE) (33). The 5-component cognitive composite measures were originally selected to represent tasks 
that are sensitive to normative age changes, and which could be reliably and briefly assessed by lay interviewers. The 
cross sectional decline in cognitive function was estimated to approximately two and a half standard deviation from 
age 45 to 90 years (34). The specific tasks included a fluency task, which involved the number of animals an individual 
could name in a 1-minute interval, forward and backward digit span, and immediate and delayed recall of a 12-item 
list. The cognitive composite score (CCS) was computed separately for each cohort by taking the sum of the five 
standardized measures, separately from each cohort (33). The widely used MMSE ranges from 0 to 30 and can be 
graded as severely impaired for scores between 0 and 17, mildly impaired for scores between 18 and 23 and normal 
for scores between 24 and 30. 
 
Genotyping and quality control 
DNA from 1905 birth cohort participants was either extracted from blood spots using the QIAamp DNA Mini and Micro 
Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol, or from whole blood using a salting out 
method (35).  
6 
 
DNA from participants in the 1910 and 1915 cohorts was extracted from dried blood spots as previously described 
(36). 
KL genotype data for the 1905 birth cohort were drawn from a previous study investigating the known genetic 
variation of a large number of candidate aging-related genes (24). Tagging SNPs with a minor allele frequency of at 
least 5%, and covering the majority of the common variation in the coding region plus 5,000 bp upstream and 1,000 
bp downstream of the gene were selected and genotyped using the Illumina GoldenGate platform (Illumina Inc, San 
Diego, CA, USA). Genotype data for a total of nineteen KL tagging SNPs in 1,088 individuals was available for the 
present study. 
For the 1910 and 1915 birth cohorts, KL genotype data was drawn from an existing genome wide data set previously 
acquired using the Illumina HumanOmniExpress BeadChips (Illumina, San Diego, CA, USA) (36). Eight of the nineteen 
tagging SNPs in the KL region were present in this data set and passed the quality control (QC) criteria; rs398655, 
rs562020, rs495392, rs2283368, rs9526984, rs2320762, rs657049, and rs648202. Two additional SNPs, rs9527024 and 
rs683907, were used as proxies, since they were in perfect LD with for the initially selected tagging SNPs, rs9536314 
and rs564481, respectively. The pair-wise LD estimates were obtained using the SNAP database (Broad institute, MIT) 
based on the 1000 Genomes pilot 1 data set and the CEU population panel (37). Genotype data were retrieved for a 
total of 405 study participants, who were all older than 96 years of age.  
 
Statistical analyses 
Statistical analyses were performed using STATA 10.1 (StataCorp, Texas, USA). The influence of KL variants were 
assessed by linear regression analysis applying an additive genetic model and using intake measures adjusted for age, 
sex and time (birth year from 1905 coded as 0, 5 and 10). Data were analyzed in the combined 1905, 1910, and 1915 
cohort group with 1 df on genotypes recoded 0, 1 and 2, where 0 are homozygotes for the major allele, 1 are 
heterozygotes, and 2 are homozygotes of the minor allele. Additionally, stratified analyses were performed by 
including the 1905 birth cohort and the 1910-1915 cohorts independently. Both the CCS and the MMSE were analysed 
as continuous variables. Subsequently, the KL-VS genotypes were analysed as categorical variables to test a non-
additive model. Post-hoc linear regression analyses was performed on selected SNPs using the additive genetic model 
with and with-out the inclusion of an interaction term. Haplotypes of rs562020 and rs398655 were analysed on the 
combined cohort using linear regression analyses. Interactions were studied in categories of low vs. high cognition and 
presence/absence of the the rs562020 and rs398655 AG haplotype and the KL-VS genotypes. Odds ratios were 
calculated using logistic regression adjusted for age, age and birth year.   
The 1905 cohort participants were assessed by cognitive measures in 1998, 2000, 2003 and 2005. A random effects 
model was applied to this cohort to perform analyses of the associations between KL variants and both the intercept 
and the slope of cognitive functioning separately within the 1905 birth cohort, since this cohort was assessed 
repeatedly with a follow-up time of up to seven years. By using a random effects model we considered the time from 
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intake and the fact that some participants were assessed 2-4 times. The annual linear slope of decline was estimated 
for both CCS and MMSE among the 1905 cohort participants. Analyses included additive genetic modes with 
genotypes coded as 0, 1 and 2 as written above for regression analysis. Sex and time from intake was 
included as covariates. The intercept was defined as the level of the cognitive functioning at the age of 93 as 
described in details elsewhere (38).  
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Results 
 
Study population and genotypes 
The study population comprised three cohorts of oldest old born in 1905, 1910 or 1915. Descriptives of the cohorts; 
mean age, assessment date and mean cognitive performance CCS and MMSE are presented in Table 1. The estimated 
annual linear slope of decline for CCS and MMSE among the 1905 cohort is described in details elsewhere (38). 
Descriptives of the nineteen KL tagging SNPs in the 1905 birth cohort and the ten equivalent SNPs or proxy SNPs in the 
1910 and 1915 birth cohorts are shown in Table 2. All gene variants, except rs397703 and rs1207362, were in Hardy-
Weinberg equilibrium (HWE) (p>0.05). 
 
Cross-sectional analysis of KL variants and cognitive function 
Carriers of the functional KL-VS variant, as determined by either rs9536314 or the proxy rs9527024, had a poorer 
cognitive function than non-carriers when assessed using the MMSE (β: -0.59, p=0.046). This association was, 
however, only borderline significant and not reflected in the CCS (β: -0.06, p=0.74). Of note those homozygous for the 
KL-VS variant (N=38) had a better cognitive function than non-carriers, thus we subsequently applied a restricted 
model suggested by Dubal and co-workers that leaves out the homozygous KL-VS carriers from the analysis. This 
model was slightly better than the additive model, as heterozygous carriers of KL-VS had 1/10 of a SD poorer cognitive 
function in the CCS (β: -0.40, p=0.06) and 1/7 of a SD poorer cognitive function in the average MMSE (β: -0.81, p=0.02) 
than non-carriers. 
In contrast, two variants, rs398655 and rs562020, that are located in the 5’ end of the gene region were found to 
associate with both MMSE and CCS. The rs398655 variant is located upstream from the coding region, and carriers of 
the rs398655 C allele had better cognitive function than non-carriers both on the CCS (β: 0.35, p=0.008) and the 
MMSE (β: 0.64, p=0.003). Regarding the other variant, rs562020, which is located in the 5’end of the first intron, 
carriers of the A allele were found to have better cognitive function than non-carriers based on both the CCS (β: 0.30, 
p=0.03) and the MMSE (β: 0.54, p=0.02) (Table 3). 
 
The effects of the rs398655 and rs562020 variants were investigated using post-hoc statistical regression models both 
including and leaving-out an interaction term. When repeating the analyses conditioning on the KL-VS variant, the 
associations between the rs398655 variant or the rs562020 variant and MMSE or CCS remained virtually unchanged, 
suggesting that these variants associate to cognition independently of KL-VS. Also, there was no interaction between 
the KL-VS variant and the variants rs398655 and rs562020. However, there was significant interaction between 
rs562020 and rs398655 (p<0.004), but the two variants are only in partial LD (D´=0.62, R2=0.27). Thus, haplotype 
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analyses were carried out and as illustrated in the combined analysis (All) in Table 4 the analyses revealed that the 
haplotype, rs398655/rs562020 AG, i.e. the haplotype not carrying any of the minor alleles, was significantly associated 
with poorer CCS equivalent to 1/5 of a standard deviation (β: -0.76, p=0.001) and 1/5 of a standard deviation poorer 
MMSE (β: -1.10, p=0.003). Thus the haplotype effect was larger than that of KL-VS in the oldest old. Also the haplotype 
association was strikingly consistent as the associations remained statistical significant across two cognitive measures 
in the two cohort strata (Table 4).  As displayed in Table 5 more individuals are cognitive impaired among carriers of 
the AG haplotype than non-carriers equivalent to an increased risk (Odds Ratio) of 45%  for being severely impaired 
(MMSE <18) and an 37% higher risk of having  a CCS lower then the mean (CCS <0.21) among non-carriers of the KL-VS 
variant (WT). The genotype restricted analyses not only illustrate the effect of the AG haplotype, but they also show 
that the AG haplotype is not an underlying effect of the KL-VS variant. In contrast the risk of the AG haplotype was 
much smaller and did not reach significance among heterozygotes KL-VS carriers.   
 
Longitudinal analysis of KL variants and cognitive function 
The effect of KL variants on change of cognitive functioning was studied among the 1905 birth cohort participants, 
who were 92-93 years of age when entering the study and were followed until their 100 year birthday. No significant 
associations with cognitive decline were observed for the KL-VS variant, the rs398655 variant or the rs562020 variant. 
However, there was a tendency for the rs398655C allele to be associated with a steeper rate of cognitive decline as 
compared to non-carriers (slope: 0.08, p-value: 0.08). Similarly, a more rapid cognitive decline was observed for 
carriers of the rs22833368 G allele compared with non-carriers with respect to the CCS (slope: -0.19, p-value: 0.008). 
In addition, carriers of the rs9526984 G allele declined more rapidly than non-carriers when assessed on the MMSE 
(slope: -0.38, p-value: 0.02) (Table 6).  
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Discussion 
The KL gene has recently been proposed to be relevant for normal cognitive functioning. In the present work most of 
the common genetic variation in KL was tagged using nineteen polymorphic variants of which ten variants were 
studied across three cohorts of oldest old. Here we observed several associations between cognitive function and the 
minor alleles of gene variants in the coding region and upstream of KL, which indicates that KL may be relevant in 
cognitive function among the oldest old. Our most noteworthy results are the consistent association with cognition 
across two measures of cognitive performance, CCS and MMSE, of the upstream positioned rs398655 variant, and the 
rs562020 variant, situated in the far 5’ end of the first intron of KL. Also it is noteworthy that the effect of the 
combined AG haplotype of these variants was larger than the effect of the most intensively studied variant in KL, the 
KL-VS variant, in the oldest old. In addition, the rs2283368 and rs9526984 variants were significantly associated with 
the slope of decline, but these were also restricted to only one of the two cognitive measures. 
 
In the present work the KL-VS variant was associated with poorer cognitive performance on the MMSE scale and this 
was further supported when applying the Dubal and co-workers model restricted to heterozygous KL-VS variant 
carriers and non-carriers, which led the results in the CCS to become borderline significant. Nonetheless, these results 
are contrary to those found recently by Dubal and co-workers (28). We can not rule out that the results in the present 
work may simply be chance findings, but we must emphasize that both CCS, MMSE and Dubal and co-workers 
cognitive tests are combined tests that share elements of working memory in addition to specific elements i.e. 
speeded tasks in CCS and basic orientation tasks in MMSE.  Another explanation for the difference in the two studies is 
that the association is age-dependent; This is supported by the notion that our observations were made among 92+ 
year old individuals, whereas the initially report by Dubal and co-workers was observed among middle aged and 
elderly individuals with a maximum age of 85 years. Secondly, Dubal and co-workers reported a potential regression 
toward the mean with age, a tendency that could continue to the oldest old ages thereby supporting the discordance 
between the two studies (28). Thirdly, an age dependent effect of the KL-VS variant has analogously been observed in 
longevity studies (26). Thus the KL gene variant may exemplify that a genetic effect can be age-dependent not only for 
mortality, but also for aging phenotypes such as cognitive function.      
  
The novel finding that the rs562020 variant is associated with cognitive performance could be of substantial interest, 
since the variant is situated in a potential regulatory element. Also, rs562020 is not in LD with other variants with 
obviously functional effects according to the HaploReg V2 database (Broad institute, MIT). Additionally, rs562020 
uniquely modifies a binding site for the zinc-finger transcriptional repressor protein, RP58, which in mice is a key 
regulator of neuronal migration (39). The rs398655 variant may likewise be important in gene regulation, but it seems 
more obvious that the association is caused by one or several other variants in LD with rs398655. Many of these 
variants were not investigated in the present study and are both located in enhancer elements and/or modify one or 
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several transcriptional binding sites. An alternative hypothesis is that rs398655 causes a missense variation, H585Q, in 
a yet only hypothetically predicted transcript (XM_005266617) that expectedly encodes an uncharacterized protein 
LOC101927403 (NCBI database). Similarly, the variant G395A (rs1207568), which is important in other age-related 
phenotypes, is predicted to be a missense variant, P85S, in the same transcript, but in the present work it was not 
found to be associated with cognition (by proxy rs397703). The complexity of the KL gene variants, including rs398655 
and rs562020, i.e. whether they themselves are functional or whether they are proxies for functional variants, is 
difficult to deduce. One way of understanding the complexity is by functional studies that characterize the regulatory 
elements of the KL gene as well as the possible role of the hypothetical protein LOC101927403. Another inform came 
from our haplotype analyses that suggest a combined role of rs398655 and rs562020, since the AG haplotype, which is 
composed of the major alleles of the two variants, was robustly associated with a poorer cognitive level across both 
cognitive measures and cohort strata and even independent of KL-VS. Since the effect was even stronger than that of 
KL-VS we suggest that this haplotype is a risk factor for cognitive deterioration and function in the oldest old. The 
notion that multiple genetic variations in KL are important is supported by other genetic variants, C1818T and G395A, 
which were previously associated with various phenotypes.  
There are several advantages to this study. First of all, we used tagging SNPs to cover the major part of the genetic 
variation in KL, and thus we were able to detect novel associations with SNPs other than the most obvious candidate 
SNPs, C1818T, G395A and KL-VS. Secondly, the span of cognitive function varies more at extreme old ages compared 
with at younger ages, and thus there is likely a gain of power by studying oldest old participants. Thirdly, it is possible 
that some gene variants associate more strongly with cognition in selected populations, such as the oldest old, 
compared to less age-selected populations. If these scenarios indeed are the reasons why we observed associations 
between novel KL variants and cognition, then our study set-up might be ideal for identifying other novel gene 
variants in relation to cognitive functioning. 
  
Our study also included a longitudinal analysis enabling us to examine the genetic effect of cognitive decline at the 
very old ages. We did not find a consistent impact of any of the KL variants on the slope of cognitive decline, but a 
tendency towards an association between a higher cognitive level and a more rapid decline was observed for the 
rs398655 C allele. This is similar to an observation found for variants in the CLU gene, and it probably indicates a 
regression towards the mean. We previously suggested that this trend could be explained by individuals with a high 
initial cognitive level having more room for declining compared to those with a lower initial cognitive level (38). In 
contrast, Deary and co-workers stressed that their longitudinal cohort study showed that the KL-VS gene variant 
associated with intelligence similarly in early and old age, thus suggesting that the KL-VS gene variant may impact on 
cognition in a large span of life (27). However, their study participants were younger than participants in the present 
work and their findings may therefore not necessarily apply to the oldest old.  
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There are also several drawbacks to our study that should be mentioned. First of all, the study only includes oldest old 
Danes, thus our novel findings may not necessarily be generalised to younger cohorts. Also our results may only apply 
to participants who are within the normal range cognitively and can not necessarily be extrapolated to clinically 
relevant functional decline. Secondly, there may be population differences that could influence the effects of the 
association between KL variants and cognition when generalised to other populations. One such explanation could be 
that the KL-VS variant is common in European populations and almost non-existing in East Asian populations.  
 
In conclusion, we suggest that several KL variants are important for normal-range cognitive function in the oldest old. 
Also, we present evidence that suggests the genetic effect of KL-VS carriers on cognitive function is dependent on the 
ages of the elderly individuals. Thus our results suggest age is a crucial factor both when exploring novel associations 
between gene variants and age-related phenotypes and when exploring known gene candidates in associations with 
new phenotypes. 
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 1905 birth cohort 1910 birth cohort 1915 birth cohort 
Assessment year 1998 2000 2003 2005 2010 2010 
Age, years (SD) 93.14 (0.31) 95.26 (0.31) 97.63 (0.28) 99.64 (0.29) 100.25 (0.32) 95.26 (0.29) 
Number of individuals 1651 901 383 182 162 158 
Completed CCS  1578 786 274 109 162 158 
Mean CCS (SD) 0.23 (3.47) 0.19 (4.15) 0.21 (3.51) 0.30 (3.72) -0.55 (3.65) 0.84 (3.48) 
Completed MMSE 1583 774 292 138 159 158 
Mean MMSE (SD) 21.77 (5.78) 21.18 (6.27) 20.27 (6.60) 19.86 (6.36) 21.32 (6.57) 23.70 (4.98) 
 
Table 1: Descriptives in the 1905 birth cohort at baseline in 1998 and follow up in 2000, 2003, and 2005.  
The 1910 birth cohort and the 1915 birth cohort at baseline in 2010.   
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SNPs Position1 Variant location 1905 birth cohort 
 
1910 and 1905 birth  
cohorts combined 
 
   Major/Minor allele MAF Major/Minor allele MAF 
rs397703¤   33,587,329  Upstream gene variant A/G 0.21 - - 
rs398655   33,587,652 Upstream gene variant  
XM_005266617: missense variant H585Q 
A/C 0.43 A/C 0.43 
rs562020   33,592,070 Intron 1 variant G/A 0.34 G/A 0.32 
rs495392   33,592,193 Intron 1 variant C/A 0.29 C/A 0.28 
rs385564   33,592,409 Intron 1 variant C/G 0.28 - - 
rs575536   33,592,777 Intron 1 variant G/A 0.27 - - 
rs576404   33,593,100 Intron 1 variant C/A 0.44 - - 
rs2283368   33,593,270 Intron 1 variant A/G 0.11 A/G 0.13 
rs9526984   33,609,937 Intron 1 variant A/G 0.09 A/G 0.08 
rs1207362¤  33,612,839 Intron 1 variant C/A 0.25 - - 
rs2320762  33,617,174 Intron 1 variant A/C 0.36 A/C 0.37 
rs1888057   33,622,695 Intron 1 variant G/A 0.20 - - 
rs657049   33,622,817 Intron 1 variant A/G 0.28 A/G 0.31 
rs683907*  33,624,175 Intron 1 variant - - A/G 0.41 
rs687045   33,624,889 Intron 1 variant A/G 0.44 - - 
rs9536314#   33,627,138 Missence F352V exon 2 A/C 0.15 - - 
rs9527024#  33,627,693 Intron 1 variant - - G/A 0.16 
rs9527026  33,628,239 Synonymous variant K385K G/A 0.16 - - 
rs522796   33,630,055 Intron 3 variant A/G 0.41 - - 
rs564481   33,634,983 Synonymous variant H589H exon 4 G/A 0.44 - - 
rs648202*  33,635,463 Synonymous variant A749A exon 4 G/A 0.15 G/A 0.15 
 
Table 2: Genotype distribution and minor allele frequency (MAF) estimations for the 1905 birth cohort and 
combined for the 1910 and 1905 birth cohorts.   
 
1Genomic position according to genome build GRCh37/hg19.on chromosome 13. 
# Proxy for KL-VS variant 
* Proxy for rs564481 
¤ Not in Hardy-Weinberg equilibrium   
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 1905 birth cohort 1910 and 1915 birth cohorts All 
SNP CCS MMSE CCS MMSE CCS MMSE 
 Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. 
rs397703¤ 0.13 
(0.19) 
0.51 0.48 
(0.31) 
0.13 - - - - - - - - 
rs398655¤ 0.41 
(0.15) 
0.006 0.77 
(0.25) 
0.002 0.13 
(0.26) 
0.61 0.30 
(0.44) 
0.50 0.35 
(0.13) 
0.008 0.64 
(0.22) 
0.003 
rs562020 0.21 
(0.16) 
0.19 0.44 
(0.26) 
0.09 0.54 
(0.28) 
0.05 0.82 
(0.47) 
0.08 0.30 
(0.14) 
0.03 0.54 
(0.23) 
0.02 
rs495392  0.20 
(0.17) 
0.24 0.50 
(0.28) 
0.07 0.20 
(0.29) 
0.49 -0.02 
(0.50) 
0.97 0.21 
(0.15) 
0.16 0.35 
(0.24) 
0.15 
rs385564  -0.02 
(0.16) 
0.92 -0.67 
(0.27) 
0.01 - - - - - - - - 
rs575536 -0.07 
(0.17) 
0.70 0.41 
(0.28) 
0.14 - - - - - - - - 
rs576404 0.02 
(0.15) 
0.89 0.24 
(0.24) 
0.32 - - - - - - - - 
rs2283368  0.44 
(0.23) 
0.06 0.04 
(0.38) 
0.91 0.14 
(0.37) 
0.71 0.68 
(0.63) 
0.29 0.36 
(0.20) 
0.07 0.24 
(0.32) 
0.46 
rs9526984 0.31 
(0.26) 
0.24 -0.14 
(0.43) 
0.74 -1.08 
(0.46) 
0.02 -1.52 
(0.79) 
0.06  -0.04 
(0.23) 
0.85 -0.51 
(0.38) 
0.18 
rs1207362 -0.04 
(0.17) 
0.80 -0.06 
(0.27) 
0.84 - - - - - - - - 
rs2320762  0.09 
(0.15) 
0.56 -0.05 
(0.25) 
0.83 -0.62 
(0.27) 
0.02 -1.06 
(0.45) 
0.02 -0.10 
(0.13) 
0.46 -0.32 
(0.22) 
0.14 
rs1888057 0.23 
(0.19) 
0.23 0.28 
(0.32) 
0.38 - - - - - - - - 
rs657049  0.23 
(0.17) 
0.18 0.11 
(0.28) 
0.70 -0.26 
(0.28) 
0.35 -0.43 
(0.47) 
0.36 0.10 
(0.15) 
0.50 -0.05 
(0.24) 
0.84 
rs687045 -0.15 
(0.15) 
0.32 -0.08 
(0.25) 
0.75 - - - - - - - - 
rs9536314# /rs9527024 0.07 
(0.21) 
0.75 -0.64 
(0.34) 
0.06 -0.40 
(0.34) 
0.24 -0.47 
(0.59) 
0.42 -0.06 
(0.18) 
0.74 -0.59 
(0.30) 
0.046 
rs9527026 0.07 
(0.21) 
0.75 -0.48 
(0.34) 
0.16 - - - - - - - - 
rs522796 0.07 
(0.15) 
0.65 0.31 
(0.25) 
0.22 - - - - - - - - 
rs564481/rs683907 -0.13 
(0.15) 
0.36 -0.01 
(0.25) 
0.97 0.49 
(0.26) 
0.06 1.05 
(0.46) 
0.02 0.02 
(0.13) 
0.86 0.28 
(0.22) 
0.21 
rs648202 0.29 
(0.22) 
0.17 0.79 
(0.35) 
0.03 -0.17 
(0.39) 
0.66 -0.48 
(0.66) 
0.47 0.19 
(0.19) 
0.33 0.46 
(0.31) 
0.14 
 
Table 3: Cross-sectional association study of KL gene variants and CCS and MMSE at intake of the 
participants in the 1905, 1910 and 1915 birth cohorts.  
Analyses were conducted using a linear regression model and a genetic additive model adjusted for age, 
sex and time (year of birth). Significant results are in italic (p<0.05). se = Standard error  
 
¤ Upstream of the KL gene 
# Tagging the KL-VS variant   
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  1905 birth cohort 1910 and 1915 birth cohorts All 
Haplotypes Estimated 
frequency 
CCS MMSE CCS MMSE CCS MMSE 
  Coef. (se) 
p-val. Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. Coef. 
(se) 
p-val.* Coef. 
(se) 
p-val.* 
AG 
 
0.50 
 
-0.63 
(0.26) 
0.01 -0.95 
(0.42) 
0.03 -1.08 
(0.44) 
0.01 -1.48 
(0.75) 
0.049 -0.76 
(0.22) 
0.001 
 
-1.10 
(0.37) 
0.003 
 
AA 
 
0.08 
 
-0.19 
(0.22) 
0.38 -0.10 
(0.36) 
0.78 -0.55 
(0.39) 
0.15 -0.41 
(0.65) 
0.53 -0.28 
(0.19) 
0.13 
 
-0.19 
(0.31) 
0.54 
 
CG 
 
0.16 
 
0.22 
(0.22) 
0.32 0.59 
(0.35) 
0.10 -1.08 
(0.37) 
0.003 -1.28 
(0.63) 
0.04 -0.12 
(0.19) 
0.51 
 
0.07 
(0.31) 
0.83 
 
CA 
 
0.27 
 
0.14 
(0.21) 
0.51 0.42 
(0.35) 
0.23 0.08 
(0.37) 
0.82 0.25 
(0.63) 
0.69   0.13 
(0.19) 
0.48 
 
  0.36 
(0.31) 
0.24 
 
 
Table 4: Cross-sectional haplotype study with CCS and MMSE at intake of the participants in the 1905, 1910 
and 1915 birth cohort. Haplotypes were estimated from rs398655 and rs562020.  
Analyses were conducted using a linear regression model and a model adjusted for age, sex and time (year 
of birth).  Significant results are in italic (p<0.05). Standard errors are abbreviated se   
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 Haplotype AG absent 
% severely impaired 
(N) 
Haplotype AG present 
% severely impaired 
(N) 
OR (95% CI) 
WT 15 % (275) 20 %  (772) 1.45 (1.00-2.13) 
Heterozygous KL-VS 22 % (25) 22 % (314) 1.05 (0.49-2.25) 
Homozygous KL-VS 0 % (3) 18 % (34)  
OR (95% CI) 1.72 (0.78-3.80) 1.21 (0.88-1.67)  
    
 Haplotype AG absent 
% with low cognition 
on the CCS 
(N) 
Haplotype AG present 
% with low cognition 
on the CCS 
(N) 
OR (95% CI) 
WT 42 % (275) 49 %  (772) 1.37 (1.03-1.80) 
Heterozygous KL-VS 53 % (25) 50 % (314) 0.88 (0.46-1.66) 
Homozygous KL-VS 0 % (3) 32 % (34)  
OR (95% CI) 1.61 (0.85-3.03) 1.05 (0.80-1.36)  
 
Table 5: Summery statistics of the proportion of cognitive impaired participants in the combined cohort. 
The upper table displays the percentage of severely impaired individuals (MMSE <18), and the lower table  
display the percentage of individuals with a cognition (CCS) lower than the mean (CCS less than 0.21). Total 
numbers are in brackets. The groups are stratified by the presence/absence of the AG, rs398655 and 
rs562020 haplotype and by the KL-VS genotype. Homozygous KL-VS are not included in Odds Ratio (OR) 
calculations. OR are adjusted for sex, age and birth year and presented in columns or rows with reference 
to the KL Wild Type (WT) or absence of the AG haplotype.  
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SNP CCS  
Baseline 
CCS 
Slope 
MMSE 
Baseline 
MMSE 
Slope 
 Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. Coef. 
(se) 
p-val. 
rs397703¤  0.10 
(0.19) 
0.60 -0.11 
(0.06) 
0.07 0.47 
(0.31) 
0.14 -0.17 
(0.12) 
0.14 
rs398655¤ 0.41 
(0.15) 
0.007 -0.08 
(0.05) 
0.08 0.80 
(0.25) 
0.001 -0.08 
(0.09) 
0.40 
rs562020  0.17 
(0.16) 
0.29 -0.04 
(0.05) 
0.46 0.42 
(0.26) 
0.11 0.10 
(0.10) 
0.32 
rs495392  0.14 
(0.17) 
0.41 -0.08 
(0.06) 
0.13 0.54 
(0.28) 
0.05 -0.07 
(0.10) 
0.48 
rs385564  -0.04 
(0.17) 
0.80 -0.05 
(0.05) 
0.41 -0.68 
(0.27) 
0.01 0.03 
(0.10) 
0.82 
rs575536  0.03 
(0.17) 
0.84 0.08 
(0.05) 
0.16 0.44 
(0.28) 
0.12 -0.04 
(0.10) 
0.67 
rs576404  -0.06 
(0.15) 
0.70 0.01 
(0.05) 
0.98 0.22 
(0.24) 
0.37 0.01 
(0.09) 
0.91 
rs2283368  0.35 
(0.24) 
0.14 -0.19 
(0.07) 
0.008 0.03 
(0.38) 
0.94 0.03 
(0.14) 
0.81 
rs9526984  0.24 
(0.27) 
0.38 -0.14 
(0.09) 
0.10 -0.01 
(0.43) 
0.99 -0.38 
(0.16) 
0.02 
rs1207362 -0.02 
(0.17) 
0.91 0.08 
(0.05) 
0.13 -0.08 
(0.27) 
0.78 0.10 
(0.10) 
0.30 
rs2320762  0.08 
(0.15) 
0.61 0.03 
(0.05) 
0.57 -0.02 
(0.25) 
0.94 -0.09 
(0.09) 
0.31 
rs1888057 0.30 
(0.20) 
0.13 -0.09 
(0.07) 
0.18 0.24 
(0.32) 
0.46 0.08 
(0.12) 
0.53 
rs657049  0.28 
(0.17) 
0.11 -0.10 
(0.06) 
0.09 0.13 
(0.28) 
0.65 -0.05 
(0.10) 
0.61 
rs687045  -0.22 
(0.15) 
0.15 0.03 
(0.05) 
0.52 -0.11 
(0.25) 
0.65 0.08 
(0.10) 
0.39 
rs9536314#  -0.01 
(0.21) 
0.99 -0.11 
(0.07) 
0.10 -0.62 
(0.34) 
0.07 -0.12 
(0.13) 
0.33 
rs9527026 -0.03 
(0.21) 
0.90 -0.10 
(0.07) 
0.13 -0.51 
(0.34) 
0.13 -0.15 
(0.13) 
0.23 
rs522796  0.16 
(0.15) 
0.29 0.04 
(0.05) 
0.39 0.35 
(0.25) 
0.16 -0.02 
(0.09) 
0.87 
rs564481 -0.19 
(0.15) 
0.22 0.04 
(0.05) 
0.45 -0.03 
(0.25) 
0.90 0.09 
(0.09) 
0.34 
rs648202  0.41 
(0.22) 
0.06 -0.05 
(0.08) 
0.48 0.73 
(0.35) 
0.04 0.04 
(0.13) 
0.79 
 
Table 6: The longitudinal association study of KL gene variants associated with CCS and MMSE by random 
effect models at intercept 93 years of age and yearly decline (slope) for participants in the 1905 birth 
cohort. Analyses were adjusted for sex and time from intake. Standard errors are abbreviated se. 
Significant results are in italic (p<0.05).  
¤ Upstream of the KL gene 
#  KL-VS variant  
 
